InterWell Health

2022: Creation of a company

On March 21, 2022, Fresenius Medical Care announced that, along with American InterWell Health and Cricket Health, the group of companies agreed to a three-way merger with its Fresenius Health Partners division.

The formed company is estimated at $2.4 billion and will operate under the brand name InterWell Health. The company will be fully consolidated by Fresenius Medical Care (FMC), which will become its majority owner. InterWell Health will be split from Fresenius Medical Care, executives said. The initial merger into InterWell Health aims to manage medical costs worth about $11 billion by 2025.

Fresenius Medical has created a company for the treatment of kidney diseases worth $2.4 billion

The merger brings together the expertise of Fresenius Health Partners, a division of Fresenius Medical Care North America, in contracting for kidney care services. The network of more than 1.6 thousand nephrologists InterWell Health will include a technological model of care, as well as a platform for involving patients of the startup Cricket Health. As part of the transaction, 1.1 thousand doctors included in the InterWell Health network will become shareholders of the company. The transaction to be reviewed by regulators is expected to close in the second half of 2022.

Шаблон:Quote 'These efforts are an important next step in implementing Fresenius Medical Care 2025 growth strategy aimed at further expansion throughout the entire renal care cycle, "said Fresenius Medical Care Executive Director Rice Powell. InterWell Health has the financial and strategic support of leading investors, including Valtruis, Oak HC/FT, Cigna Ventures and Blue Shield of California, who supported Cricket Health. According to the company's executives, with a total market volume of $170 billion as of March 2022, the company will accelerate the treatment of patients with chronic kidney disease in the middle and late stages receiving value-oriented treatment.^[1]

Notes